市場調査レポート
商品コード
1087409

静菌性注射用水の世界市場:2022年~2026年

Global Bacteriostatic Water for Injection Market 2022-2026

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
静菌性注射用水の世界市場:2022年~2026年
出版日: 2022年06月07日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の静菌性注射用水の市場規模は、2022年から2026年の間に22億8,000万米ドル成長し、予測期間中は6.6%のCAGRで成長する見込みです。

同市場は、バイオ医薬品およびジェネリック注射剤産業の成長、静菌性注射用水の多様な用途、規制当局の承認の増加などに牽引されています。

当レポートでは、静菌性注射用水の世界市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、および約25のベンダーをカバーする分析を提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場のエコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 2021年の市場規模
  • 市場の見通し:2021年から2026年の予測

第4章 ファイブフォース分析

  • ファイブフォースまとめ
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第5章 市場セグメンテーション:エンドユーザー別

  • 市場セグメント
  • エンドユーザー別の比較
  • 病院:市場規模と予測(2021年~2026年)
  • クリニック:市場規模と予測(2021年~2026年)
  • その他:市場規模と予測(2021年~2026年)
  • エンドユーザー別の市場機会

第6章 顧客情勢

  • 顧客情勢の概要

第7章 地域別情勢

  • 地域別セグメンテーション
  • 地域別の比較
  • 北米:市場規模と予測(2021年~2026年)
  • 欧州:市場規模と予測(2021年~2026年)
  • アジア:市場規模と予測(2021年~2026年)
  • その他の地域:市場規模と予測(2021年~2026年)
  • 米国:市場規模と予測(2021年~2026年)
  • ドイツ:市場規模と予測(2021年~2026年)
  • 英国:市場規模と予測(2021年~2026年)
  • カナダ:市場規模と予測(2021年~2026年)
  • 中国:市場規模と予測(2021年~2026年)
  • 地域情勢別の市場機会

第8章 推進要因、課題、および動向

  • 市場推進要因
  • 市場の課題
  • 推進要因と課題の影響
  • 市場動向

第9章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第10章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • AdvaCare Pharma
  • B. Braun SE
  • GlaxoSmithKline Plc
  • Medefil Inc.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • SteriMax Inc.

第11章 付録

目次
Product Code: IRTNTR73674

Technavio has been monitoring the bacteriostatic water for the injection market and it is poised to grow by $ 2.28 bn during 2022-2026, accelerating at a CAGR of 6.6% during the forecast period. Our report on the bacteriostatic water for injection market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growth of the biopharmaceutical and generic injectable drugs industries, the diverse applications of bacteriostatic water for injection, and an increase in regulatory approvals.

The bacteriostatic water for injection market analysis includes end-user segment and geographic landscape.

Technavio's bacteriostatic water for injection market is segmented as below:

By End-user

  • Hospitals
  • Clinics
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the development of new drugs and vaccines for covid-19 as one of the prime reasons driving the bacteriostatic water for injection market growth during the next few years. Also, growing use in access and use for clinical pharmacology applications will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on bacteriostatic water for injection market covers the following areas:

  • Bacteriostatic water for injection market sizing
  • Bacteriostatic water for injection market forecast
  • Bacteriostatic water for injection market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bacteriostatic water for injection market vendors that include Abbott Laboratories, AdvaCare Pharma, B. Braun SE, CAPTAB BIOTEC UNIT II, Covetrus Inc., Daiichi Sankyo Co. Ltd., Fresenius SE, and Co. KGaA, FUJIFILM Holdings Corp., GlaxoSmithKline Plc, Medefil Inc., Merck and Co. Inc., Merit Healthcare International Inc., Novartis AG, Pfizer Inc., Pharma Cure Laboratories, Sanofi, and SteriMax Inc. Also, the bacteriostatic water for injection market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user

  • 5.1 Market segments
  • Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
  • 5.2 Comparison by End-user
  • Exhibit 26: Chart on Comparison by End-user
  • Exhibit 27: Data Table on Comparison by End-user
  • 5.3 Hospitals - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
  • 5.4 Clinics - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Clinics - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Clinics - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Clinics - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Clinics - Year-over-year growth 2021-2026 (%)
  • 5.5 Others - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • 5.6 Market opportunity by End-user
  • Exhibit 40: Market opportunity by End-user ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 44: Chart on Geographic comparison
  • Exhibit 45: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 UK - Market size and forecast 2021-2026
  • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.10 Canada - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.11 China - Market size and forecast 2021-2026
  • Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 85: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 86: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 87: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 88: Matrix on vendor position and classification
  • 10.3 Abbott Laboratories
  • Exhibit 89: Abbott Laboratories - Overview
  • Exhibit 90: Abbott Laboratories - Business segments
  • Exhibit 91: Abbott Laboratories - Key news
  • Exhibit 92: Abbott Laboratories - Key offerings
  • Exhibit 93: Abbott Laboratories - Segment focus
  • 10.4 AdvaCare Pharma
  • Exhibit 94: AdvaCare Pharma - Overview
  • Exhibit 95: AdvaCare Pharma - Product / Service
  • Exhibit 96: AdvaCare Pharma - Key offerings
  • 10.5 B. Braun SE
  • Exhibit 97: B. Braun SE - Overview
  • Exhibit 98: B. Braun SE - Business segments
  • Exhibit 99: B. Braun SE - Key news
  • Exhibit 100: B. Braun SE - Key offerings
  • Exhibit 101: B. Braun SE - Segment focus
  • 10.6 GlaxoSmithKline Plc
  • Exhibit 102: GlaxoSmithKline Plc - Overview
  • Exhibit 103: GlaxoSmithKline Plc - Business segments
  • Exhibit 104: GlaxoSmithKline Plc - Key news
  • Exhibit 105: GlaxoSmithKline Plc - Key offerings
  • Exhibit 106: GlaxoSmithKline Plc - Segment focus
  • 10.7 Medefil Inc.
  • Exhibit 107: Medefil Inc. - Overview
  • Exhibit 108: Medefil Inc. - Product / Service
  • Exhibit 109: Medefil Inc. - Key offerings
  • 10.8 Merck and Co. Inc.
  • Exhibit 110: Merck and Co. Inc. - Overview
  • Exhibit 111: Merck and Co. Inc. - Business segments
  • Exhibit 112: Merck and Co. Inc. - Key news
  • Exhibit 113: Merck and Co. Inc. - Key offerings
  • Exhibit 114: Merck and Co. Inc. - Segment focus
  • 10.9 Novartis AG
  • Exhibit 115: Novartis AG - Overview
  • Exhibit 116: Novartis AG - Business segments
  • Exhibit 117: Novartis AG - Key offerings
  • Exhibit 118: Novartis AG - Segment focus
  • 10.10 Pfizer Inc.
  • Exhibit 119: Pfizer Inc. - Overview
  • Exhibit 120: Pfizer Inc. - Product / Service
  • Exhibit 121: Pfizer Inc. - Key news
  • Exhibit 122: Pfizer Inc. - Key offerings
  • 10.11 Sanofi
  • Exhibit 123: Sanofi - Overview
  • Exhibit 124: Sanofi - Business segments
  • Exhibit 125: Sanofi - Key news
  • Exhibit 126: Sanofi - Key offerings
  • Exhibit 127: Sanofi - Segment focus
  • 10.12 SteriMax Inc.
  • Exhibit 128: SteriMax Inc. - Overview
  • Exhibit 129: SteriMax Inc. - Product / Service
  • Exhibit 130: SteriMax Inc. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 131: Inclusions checklist
  • Exhibit 132: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 133: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 134: Research methodology
  • Exhibit 135: Validation techniques employed for market sizing
  • Exhibit 136: Information sources
  • 11.5 List of abbreviations
  • Exhibit 137: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on End-user - Market share 2021-2026 (%)
  • Exhibits25: Data Table on End-user - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by End-user
  • Exhibits27: Data Table on Comparison by End-user
  • Exhibits28: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Clinics - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Clinics - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Clinics - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Clinics - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Market opportunity by End-user ($ million)
  • Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits44: Chart on Geographic comparison
  • Exhibits45: Data Table on Geographic comparison
  • Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Market opportunity By Geographical Landscape ($ million)
  • Exhibits83: Impact of drivers and challenges in 2021 and 2026
  • Exhibits84: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits85: Overview on factors of disruption
  • Exhibits86: Impact of key risks on business
  • Exhibits87: Vendors covered
  • Exhibits88: Matrix on vendor position and classification
  • Exhibits89: Abbott Laboratories - Overview
  • Exhibits90: Abbott Laboratories - Business segments
  • Exhibits91: Abbott Laboratories - Key news
  • Exhibits92: Abbott Laboratories - Key offerings
  • Exhibits93: Abbott Laboratories - Segment focus
  • Exhibits94: AdvaCare Pharma - Overview
  • Exhibits95: AdvaCare Pharma - Product / Service
  • Exhibits96: AdvaCare Pharma - Key offerings
  • Exhibits97: B. Braun SE - Overview
  • Exhibits98: B. Braun SE - Business segments
  • Exhibits99: B. Braun SE - Key news
  • Exhibits100: B. Braun SE - Key offerings
  • Exhibits101: B. Braun SE - Segment focus
  • Exhibits102: GlaxoSmithKline Plc - Overview
  • Exhibits103: GlaxoSmithKline Plc - Business segments
  • Exhibits104: GlaxoSmithKline Plc - Key news
  • Exhibits105: GlaxoSmithKline Plc - Key offerings
  • Exhibits106: GlaxoSmithKline Plc - Segment focus
  • Exhibits107: Medefil Inc. - Overview
  • Exhibits108: Medefil Inc. - Product / Service
  • Exhibits109: Medefil Inc. - Key offerings
  • Exhibits110: Merck and Co. Inc. - Overview
  • Exhibits111: Merck and Co. Inc. - Business segments
  • Exhibits112: Merck and Co. Inc. - Key news
  • Exhibits113: Merck and Co. Inc. - Key offerings
  • Exhibits114: Merck and Co. Inc. - Segment focus
  • Exhibits115: Novartis AG - Overview
  • Exhibits116: Novartis AG - Business segments
  • Exhibits117: Novartis AG - Key offerings
  • Exhibits118: Novartis AG - Segment focus
  • Exhibits119: Pfizer Inc. - Overview
  • Exhibits120: Pfizer Inc. - Product / Service
  • Exhibits121: Pfizer Inc. - Key news
  • Exhibits122: Pfizer Inc. - Key offerings
  • Exhibits123: Sanofi - Overview
  • Exhibits124: Sanofi - Business segments
  • Exhibits125: Sanofi - Key news
  • Exhibits126: Sanofi - Key offerings
  • Exhibits127: Sanofi - Segment focus
  • Exhibits128: SteriMax Inc. - Overview
  • Exhibits129: SteriMax Inc. - Product / Service
  • Exhibits130: SteriMax Inc. - Key offerings
  • Exhibits131: Inclusions checklist
  • Exhibits132: Exclusions checklist
  • Exhibits133: Currency conversion rates for US$
  • Exhibits134: Research methodology
  • Exhibits135: Validation techniques employed for market sizing
  • Exhibits136: Information sources
  • Exhibits137: List of abbreviations